Stephen From
Chief Executive Officer at Aruna Bio, Inc.
Network origin in Stephen From first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA.
13
| Holding Company | Medical/Nursing Services | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephen From via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Chairman Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MindSet Rx, Inc.
 MindSet Rx, Inc. Miscellaneous Commercial ServicesCommercial Services MindSet Rx, Inc. operates as a biotech company that offers solution for neurodegenerative diseases. The company was founded by Bernard Malfroy-Camine and Michel Baudry in 2008 and is headquartered in Arlington, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Sofimac Innovation SAS
 Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor | |
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
| Boston College | College/University | Undergraduate Degree Graduate Degree | |
Eukarion, Inc.
 Eukarion, Inc. Pharmaceuticals: MajorHealth Technology Eukarion, Inc. engages in the provision of medical research. It develops small molecule drugs for the treatment of degenerative and age-related disorders. The company was founded on January 25, 1991 and is headquartered in Arlington, MA. | Pharmaceuticals: Major | President | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree | |
| University of Georgia | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
PALUMED SA
 PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Founder | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Ecole Polytechnique | College/University | Undergraduate Degree | |
Osmotica Pharmaceutical Corp.
 Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| University of Georgia Foundation | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| GENOMIC VISION | Medical Specialties | Director/Board Member | |
Eye Tech Care SA
 Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Medical Specialties | Director/Board Member | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Ora, Inc.
 Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Medical/Nursing Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| Alliances Internationale | Corporate Officer/Principal | ||
Jade Therapeutics, Inc.
 Jade Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Jade Therapeutics, Inc. develops pharmaceutical products. The company is based in Salt Lake City, UT. The company was founded by Barbara Wirostko. Jade Therapeutics was acquired by Kiora Pharmaceuticals, Inc. on March 07, 2016 for $5.10 million. | Pharmaceuticals: Major | Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| ViThera Pharmaceuticals, Inc. | Chief Executive Officer | ||
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
Emosis SAS
 Emosis SAS Miscellaneous Commercial ServicesCommercial Services Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France. | Miscellaneous Commercial Services | Director/Board Member | |
Physio-Assist SAS
 Physio-Assist SAS Medical SpecialtiesHealth Technology Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France. | Medical Specialties | Director/Board Member | |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Miscellaneous Commercial Services | Founder Founder | |
| VAXART, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Qlaris Bio, Inc.
 Qlaris Bio, Inc. BiotechnologyHealth Technology Qlaris Bio, Inc. operates as a biotechnology company. The company was founded by Thurein Htoo and Barbara Wirostko and is headquartered in Wellesley, MA. | Biotechnology | Founder | |
| Bayon Therapeutics, Inc. | Founder Founder | ||
| ALKERMES PLC | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| United States | 33 |
| France | 15 |
| Australia | 2 |
| Switzerland | 2 |
| Austria | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Finance | 4 |
| Government | 2 |
Operational
| Director/Board Member | 158 |
| Corporate Officer/Principal | 81 |
| Independent Dir/Board Member | 34 |
| Undergraduate Degree | 32 |
| Chief Executive Officer | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Greenleaf | 31 |
| Mounia Chaoui-Roulleau | 27 |
| John P. Richard | 24 |
| Praveen Tyle | 23 |
| Thomas Balland | 20 |
| Thomas Hancock | 19 |
| C. Griffin | 17 |
| Illya Keith Maher | 17 |
| Bernard Malfroy-Camine | 17 |
| Michael Ryan | 14 |
| Paul Chaney | 12 |
| Steven Boyd | 12 |
| Harold W. Ingalls | 11 |
| Ryan R. Brenneman | 10 |
| Barry Storey | 10 |
- Stock Market
- Insiders
- Stephen From
- Company connections
